Hero image

Research

We run to, not from, the world’s biggest health challenges.

The journey to discovery is guided by science – and inspired by patients

We use the power of leading-edge science to save and improve lives around the world. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.

Our work in numbers

~17.5K

people employed in research and development

285M

people reached through our major programs and partnerships

$12.2B

invested in R&D in 2021

We address the world’s most difficult health challenges, following leading-edge science

Hero_RGB_Discovery-Blue
Discovery & development

Step inside Merck Research Laboratories (MRL) where our quest to save and improve lives through research and development begins

B5 - Our pipeline__
Pipeline

We’re focused on inventing new medicines and vaccines to help more people

B5 we work to deliver
Products

Our focus on breakthrough science is working

Clinical trials

Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations. We are grateful to the thousands of volunteers who participate in our clinical trials – making this all possible.

Father playing with young son at breakfast table

Our commitment to patients is unwavering

As long as there are still patients in hospitals, doctors and nurses desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.

Discovery starts here

Our scientists are applying the latest groundbreaking research technologies and revolutionizing how we discover and develop medicines and vaccines

View our stories

Teaming up with Eisai to help fight cancer

How we're leveraging each other’s unique strengths to help advance cancer research

Read more

Next: Teaming up with Eisai to help fight cancer

Merck’s Q2 2022 earnings report

Merck’s (NYSE: MRK) Q2 2022 results deliver robust sales growth and important clinical advancements. The company announced Q2 worldwide sales of $14.6 billion, an increase of 28% from Q2 2021. “I continue to be immensely proud of how the Merck team is performing in all facets of our business – scientifically, commercially and operationally,” said Robert […]

Read more

Next: Merck’s Q2 2022 earnings report

How Merck is using 3D printing to create innovative solutions

3D technology is helping optimize workstreams, shorten turn-around times, reduce costs and drive innovation

See how

Next: How Merck is using 3D printing to create innovative solutions

Proteins in space: taking our research to the final frontier

Merck Research Laboratories scientist Paul Reichert works with the International Space Station to drive innovation

Read more

Next: Proteins in space: taking our research to the final frontier

Why we’re expanding and investing in our research and discovery efforts

Our commitment to innovation helps ensure a brighter future for patients everywhere

Read more

Next: Why we’re expanding and investing in our research and discovery efforts

Teaming up with Eisai to help fight cancer

How we're leveraging each other’s unique strengths to help advance cancer research

Read more

Next: Teaming up with Eisai to help fight cancer

Merck’s Q2 2022 earnings report

Merck’s (NYSE: MRK) Q2 2022 results deliver robust sales growth and important clinical advancements. The company announced Q2 worldwide sales of $14.6 billion, an increase of 28% from Q2 2021. “I continue to be immensely proud of how the Merck team is performing in all facets of our business – scientifically, commercially and operationally,” said Robert […]

Read more

Next: Merck’s Q2 2022 earnings report

How Merck is using 3D printing to create innovative solutions

3D technology is helping optimize workstreams, shorten turn-around times, reduce costs and drive innovation

See how

Next: How Merck is using 3D printing to create innovative solutions

Proteins in space: taking our research to the final frontier

Merck Research Laboratories scientist Paul Reichert works with the International Space Station to drive innovation

Read more

Next: Proteins in space: taking our research to the final frontier

Why we’re expanding and investing in our research and discovery efforts

Our commitment to innovation helps ensure a brighter future for patients everywhere

Read more

Next: Why we’re expanding and investing in our research and discovery efforts

Previous
Next
a cow with a blue sky background

Protecting animal health

Our Animal Health business is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them.